Skip to main content
TipRanks
Go Ultimate75% OFF

AEON Biopharma (AEON) Stock Statistics & Valuation Metrics

241 Followers

Total Valuation

AEON Biopharma has a market cap or net worth of $9.04M. The enterprise value is $35.69M.

Market Cap
$9.04M
Enterprise Value
$35.69M

Share Statistics

AEON Biopharma has 59,084,675 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
59,084,675
Owned by Insiders
70.71%
Owned by Institutions
12.04%

Financial Efficiency

AEON Biopharma’s return on equity (ROE) is 0.71 and return on invested capital (ROIC) is 1180.00%.

Return on Equity (ROE)
0.71
Return on Assets (ROA)
-7.05
Return on Invested Capital (ROIC)
1180.00%
Return on Capital Employed (ROCE)
9.58
Revenue Per Employee
0
Profits Per Employee
-4.90M
Employee Count
8
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of AEON Biopharma is -0.04. AEON Biopharma’s PEG ratio is 0.00.

PE Ratio
-0.04
PS Ratio
0.00
PB Ratio
-0.50
Price to FCF
-0.56
Price to Operating Cash Flow
-0.57
PEG Ratio
0.00

Income Statement

In the last 12 months, AEON Biopharma had revenue of 0 and earned -39.22M in profits. Earnings per share was -3.95.

Revenue
0
Gross Profit
0
Operating Income
-12.80M
Pretax Income
-39.22M
Net Income
-39.22M
EBITDA
-16.22M
Earnings Per Share (EPS)
-3.95

Cash Flow

In the last 12 months, operating cash flow was -13.64M and capital expenditures 0, giving a free cash flow of -13.64M billion.

Operating Cash Flow
-13.64M
Free Cash Flow
-13.64M
Free Cash Flow per Share
-0.27

Dividends & Yields

AEON Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-178.75%
Earnings Yield
-706.52%

Stock Price Statistics

Beta
1.55
52-Week Price Change
-83.72%
50-Day Moving Average
0.25
200-Day Moving Average
0.62
Relative Strength Index (RSI)
30.96
Average Volume (3m)
7.70M

Important Dates

AEON Biopharma upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).

Last Earnings Date
Aug 12, 2026
Next Earnings Date
Nov 18, 2026
Ex-Dividend Date
―

Financial Position

AEON Biopharma as a current ratio of 0.49, with Debt / Equity ratio of -64.96%

Current Ratio
0.49
Quick Ratio
0.49
Debt to Market Cap
3.17
Net Debt to EBITDA
-2.02
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, AEON Biopharma has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

AEON Biopharma EV to EBITDA ratio is -0.27, with an EV/FCF ratio of -0.51.

EV to Sales
0.00
EV to EBITDA
-0.27
EV to Free Cash Flow
-0.51
EV to Operating Cash Flow
-0.51

Balance Sheet

AEON Biopharma has $3.43M in cash and marketable securities with $2.77M in debt, giving a net cash position of $656.00K billion.

Cash & Marketable Securities
$3.43M
Total Debt
$2.77M
Net Cash
$656.00K
Net Cash Per Share
$0.01
Tangible Book Value Per Share
-$0.30

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for AEON Biopharma is $1.90, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
$1.90
Price Target Upside
1141.83% Upside
Analyst Consensus
Moderate Buy
Analyst Count
2
Revenue Growth Forecast
―
EPS Growth Forecast
35.03%

Scores

Smart Score
―
AI Score
45